KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,562 | +62.9% | 1,299 | +32.0% | 0.00% | – |
| Q2 2023 | $13,854 | +30.9% | 984 | 0.0% | 0.00% | – |
| Q1 2023 | $10,587 | +958.7% | 984 | +884.0% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 100 | -62.8% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 269 | +8.0% | 0.00% | – |
| Q2 2021 | $3,000 | -40.0% | 249 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +150.0% | 249 | +149.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |